3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
4
Melanoma
2
Uterine Cervical Neoplasms
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuromyelitis Optica
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Laryngectomy; Status
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Endometrial Neoplasms
1
Encephalomyelitis, Acute Disseminated
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Dexamethasone
3
isatuximab
2
Lenalidomide
2
Cyclophosphamide
2
pomalidomide
1
fludarabine phosphate
1
fludarabine
1
daratumumab
1
Watchful Waiting
1
Vorinostat
1
Vincristine
1
Specimen Handling
1
Rituximab
1
Ranitidine
1
R-CHOP protocol
1
Prednisone
1
Interviews as Topic
1
Injections
1
Histone Deacetylase Inhibitors
1
Filgrastim
1
Exercise
1
Doxorubicin
1
Diphenhydramine
1
Data Collection
1
Bortezomib
1
Acetaminophen
1
AC protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Diseases
×
Data Collection
×
Clear all
NCT03868527
2019-03-11
Arcan database
Hospices Civils de Lyon
Unknown
13,000 enrolled